234 related articles for article (PubMed ID: 19592065)
1. A QSAR-like analysis of the adsorption of endocrine disrupting compounds, pharmaceuticals, and personal care products on modified activated carbons.
Redding AM; Cannon FS; Snyder SA; Vanderford BJ
Water Res; 2009 Aug; 43(15):3849-61. PubMed ID: 19592065
[TBL] [Abstract][Full Text] [Related]
2. Ozonation and advanced oxidation technologies to remove endocrine disrupting chemicals (EDCs) and pharmaceuticals and personal care products (PPCPs) in water effluents.
Esplugas S; Bila DM; Krause LG; Dezotti M
J Hazard Mater; 2007 Nov; 149(3):631-42. PubMed ID: 17826898
[TBL] [Abstract][Full Text] [Related]
3. Year-long evaluation on the occurrence and fate of pharmaceuticals, personal care products, and endocrine disrupting chemicals in an urban drinking water treatment plant.
Padhye LP; Yao H; Kung'u FT; Huang CH
Water Res; 2014 Mar; 51():266-76. PubMed ID: 24262763
[TBL] [Abstract][Full Text] [Related]
4. A QSAR model for predicting rejection of emerging contaminants (pharmaceuticals, endocrine disruptors) by nanofiltration membranes.
Yangali-Quintanilla V; Sadmani A; McConville M; Kennedy M; Amy G
Water Res; 2010 Jan; 44(2):373-84. PubMed ID: 19616272
[TBL] [Abstract][Full Text] [Related]
5. Rejection of pharmaceuticals and personal care products (PPCPs) and endocrine disrupting chemicals (EDCs) by low pressure reverse osmosis membranes.
Ozaki H; Ikejima N; Shimizu Y; Fukami K; Taniguchi S; Takanami R; Giri RR; Matsui S
Water Sci Technol; 2008; 58(1):73-81. PubMed ID: 18653939
[TBL] [Abstract][Full Text] [Related]
6. Removing emerging contaminants.
Christen K
Environ Sci Technol; 2008 Jan; 42(1):6-7. PubMed ID: 18350867
[No Abstract] [Full Text] [Related]
7. Endocrine disrupting compounds (EDCs) and pharmaceuticals and personal care products (PPCPs) in the aquatic environment: implications for the drinking water industry and global environmental health.
Rahman MF; Yanful EK; Jasim SY
J Water Health; 2009 Jun; 7(2):224-43. PubMed ID: 19240349
[TBL] [Abstract][Full Text] [Related]
8. Oxidative removal of selected endocrine-disruptors and pharmaceuticals in drinking water treatment systems, and identification of degradation products of triclosan.
Wu Q; Shi H; Adams CD; Timmons T; Ma Y
Sci Total Environ; 2012 Nov; 439():18-25. PubMed ID: 23059968
[TBL] [Abstract][Full Text] [Related]
9. Adsorption of selected endocrine disrupting compounds and pharmaceuticals on activated biochars.
Jung C; Park J; Lim KH; Park S; Heo J; Her N; Oh J; Yun S; Yoon Y
J Hazard Mater; 2013 Dec; 263 Pt 2():702-10. PubMed ID: 24231319
[TBL] [Abstract][Full Text] [Related]
10. The occurrence of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs in surface water in South Wales, UK.
Kasprzyk-Hordern B; Dinsdale RM; Guwy AJ
Water Res; 2008 Jul; 42(13):3498-518. PubMed ID: 18514758
[TBL] [Abstract][Full Text] [Related]
11. The removal of endocrine disrupting compounds, pharmaceutically activated compounds and cyanobacterial toxins during drinking water preparation using activated carbon--a review.
Delgado LF; Charles P; Glucina K; Morlay C
Sci Total Environ; 2012 Oct; 435-436():509-25. PubMed ID: 22885596
[TBL] [Abstract][Full Text] [Related]
12. Removal of selected endocrine disrupting chemicals (EDCs) and pharmaceuticals and personal care products (PPCPs) during ferrate(VI) treatment of secondary wastewater effluents.
Yang B; Ying GG; Zhao JL; Liu S; Zhou LJ; Chen F
Water Res; 2012 May; 46(7):2194-204. PubMed ID: 22342241
[TBL] [Abstract][Full Text] [Related]
13. Removal of emerging contaminants of concern by alternative adsorbents.
Rossner A; Snyder SA; Knappe DR
Water Res; 2009 Aug; 43(15):3787-96. PubMed ID: 19577267
[TBL] [Abstract][Full Text] [Related]
14. The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters.
Kasprzyk-Hordern B; Dinsdale RM; Guwy AJ
Water Res; 2009 Feb; 43(2):363-80. PubMed ID: 19022470
[TBL] [Abstract][Full Text] [Related]
15. Prediction of adsorption capacity for pharmaceuticals, personal care products and endocrine disrupting chemicals onto various adsorbent materials.
Bunmahotama W; Lin TF; Yang X
Chemosphere; 2020 Jan; 238():124658. PubMed ID: 31548174
[TBL] [Abstract][Full Text] [Related]
16. Removal efficiency of pharmaceuticals and personal care products with varying wastewater treatment processes and operating conditions - conception of a database and first results.
Miège C; Choubert JM; Ribeiro L; Eusèbe M; Coquery M
Water Sci Technol; 2008; 57(1):49-56. PubMed ID: 18192740
[TBL] [Abstract][Full Text] [Related]
17. Fate of endocrine-disruptor, pharmaceutical, and personal care product chemicals during simulated drinking water treatment processes.
Westerhoff P; Yoon Y; Snyder S; Wert E
Environ Sci Technol; 2005 Sep; 39(17):6649-63. PubMed ID: 16190224
[TBL] [Abstract][Full Text] [Related]
18. Arsenic removal by iron-modified activated carbon.
Chen W; Parette R; Zou J; Cannon FS; Dempsey BA
Water Res; 2007 May; 41(9):1851-8. PubMed ID: 17367839
[TBL] [Abstract][Full Text] [Related]
19. Endocrine disruptors and pharmaceuticals: implications for water sustainability.
Snyder SA; Benotti MJ
Water Sci Technol; 2010; 61(1):145-54. PubMed ID: 20057100
[TBL] [Abstract][Full Text] [Related]
20. QSAR-like models: a potential tool for the selection of PhACs and EDCs for monitoring purposes in drinking water treatment systems--a review.
Delgado LF; Charles P; Glucina K; Morlay C
Water Res; 2012 Dec; 46(19):6196-209. PubMed ID: 23040564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
